Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2009

Open Access 01-08-2009 | Research article

Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases

Authors: Ghazi Chabchoub, Elif Uz, Abdellatif Maalej, Chigdem A Mustafa, Ahmed Rebai, Mouna Mnif, Zouheir Bahloul, Nadir R Farid, Tayfun Ozcelik, Hammadi Ayadi

Published in: Arthritis Research & Therapy | Issue 4/2009

Login to get access

Abstract

Introduction

The majority of autoimmune diseases such as rheumatoid arthritis (RA) and autoimmune thyroid diseases (AITDs) are characterized by a striking female predominance superimposed on a predisposing genetic background. The role of extremely skewed X-chromosome inactivation (XCI) has been questioned in the pathogenesis of several autoimmune diseases.

Methods

We examined XCI profiles of females affected with RA (n = 106), AITDs (n = 145) and age-matched healthy women (n = 257). XCI analysis was performed by enzymatic digestion of DNA with a methylation sensitive enzyme (HpaII) followed by PCR of a polymorphic CAG repeat in the androgen receptor (AR) gene. The XCI pattern was classified as skewed when 80% or more of the cells preferentially inactivated the same X-chromosome.

Results

Skewed XCI was observed in 26 of the 76 informative RA patients (34.2%), 26 of the 100 informative AITDs patients (26%), and 19 of the 170 informative controls (11.2%) (P < 0.0001; P = 0.0015, respectively). More importantly, extremely skewed XCI, defined as > 90% inactivation of one allele, was present in 17 RA patients (22.4%), 14 AITDs patients (14.0%), and in only seven controls (4.1%, P < 0.0001; P = 0.0034, respectively). Stratifying RA patients according to laboratory profiles (rheumatoid factor and anti-citrullinated protein antibodies), clinical manifestations (erosive disease and nodules) and the presence of others autoimmune diseases did not reveal any statistical significance (P > 0.05).

Conclusions

These results suggest a possible role for XCI mosaicism in the pathogenesis of RA and AITDs and may in part explain the female preponderance of these diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rougeulle C, Avner P: Controlling X-inactivation in mammals: what does the centre hold?. Semin Cell Dev Biol. 2003, 14: 331-340. 10.1016/j.semcdb.2003.09.014.CrossRefPubMed Rougeulle C, Avner P: Controlling X-inactivation in mammals: what does the centre hold?. Semin Cell Dev Biol. 2003, 14: 331-340. 10.1016/j.semcdb.2003.09.014.CrossRefPubMed
2.
go back to reference Kast RE: Predominance of autoimmune and rheumatic diseases in females. J Rheumatol. 1977, 4: 288-292.PubMed Kast RE: Predominance of autoimmune and rheumatic diseases in females. J Rheumatol. 1977, 4: 288-292.PubMed
3.
go back to reference Stewart JJ: The female × inactivation mosaic in systemic lupus erythematosus. Immunol Today. 1998, 19: 352-257. 10.1016/S0167-5699(98)01298-5.CrossRefPubMed Stewart JJ: The female × inactivation mosaic in systemic lupus erythematosus. Immunol Today. 1998, 19: 352-257. 10.1016/S0167-5699(98)01298-5.CrossRefPubMed
4.
go back to reference Klein L, Klugmann M, Nave K-A, Tuohy VK, Kyewski B: Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Med. 2000, 6: 56-61. 10.1038/71540.CrossRefPubMed Klein L, Klugmann M, Nave K-A, Tuohy VK, Kyewski B: Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Med. 2000, 6: 56-61. 10.1038/71540.CrossRefPubMed
5.
go back to reference Puck JM, Stewart CC, Nussbaum RL: Maximum likelihood analysis of human T-cell X-chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet. 1992, 50: 742-748.PubMedCentralPubMed Puck JM, Stewart CC, Nussbaum RL: Maximum likelihood analysis of human T-cell X-chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet. 1992, 50: 742-748.PubMedCentralPubMed
6.
go back to reference Kristiansen M, Knudsen GPS, Bathum L, Naumova AK, Sorensen TI, Brix TH, Svendsen AJ, Christensen K, Kyvik KO, Orstavik KH: Twin study of genetic and aging effects on X-chromosome inactivation. Eur J Hum Genet. 2005, 13: 599-606. 10.1038/sj.ejhg.5201398.CrossRefPubMed Kristiansen M, Knudsen GPS, Bathum L, Naumova AK, Sorensen TI, Brix TH, Svendsen AJ, Christensen K, Kyvik KO, Orstavik KH: Twin study of genetic and aging effects on X-chromosome inactivation. Eur J Hum Genet. 2005, 13: 599-606. 10.1038/sj.ejhg.5201398.CrossRefPubMed
7.
go back to reference Sharp A, Robinson D, Jacobs P: Age- and tissue-specific variation of X-chromosome inactivation ratios in normal women. Hum Genet. 2000, 107: 343-349. 10.1007/s004390000382.CrossRefPubMed Sharp A, Robinson D, Jacobs P: Age- and tissue-specific variation of X-chromosome inactivation ratios in normal women. Hum Genet. 2000, 107: 343-349. 10.1007/s004390000382.CrossRefPubMed
8.
go back to reference Belmont JW: Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet. 1996, 58: 1101-1108.PubMedCentralPubMed Belmont JW: Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet. 1996, 58: 1101-1108.PubMedCentralPubMed
9.
go back to reference Laufer TM, Dekoning J, Markowitz JS, Lo D, Glimcher LH: Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature. 1996, 383: 81-85. 10.1038/383081a0.CrossRefPubMed Laufer TM, Dekoning J, Markowitz JS, Lo D, Glimcher LH: Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature. 1996, 383: 81-85. 10.1038/383081a0.CrossRefPubMed
10.
go back to reference Kyewski B, Derbinski J: Self-representation in the thymus: anextended view. Nat Rev Immunol. 2004, 4: 688-698. 10.1038/nri1436.CrossRefPubMed Kyewski B, Derbinski J: Self-representation in the thymus: anextended view. Nat Rev Immunol. 2004, 4: 688-698. 10.1038/nri1436.CrossRefPubMed
11.
go back to reference Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S, Birlik AM, Calguneri M, Ozcelik T: Skewed X-chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum. 2005, 52: 1564-1570. 10.1002/art.21026.CrossRefPubMed Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S, Birlik AM, Calguneri M, Ozcelik T: Skewed X-chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum. 2005, 52: 1564-1570. 10.1002/art.21026.CrossRefPubMed
12.
go back to reference Brix TH, Knudsen GP, Kristiansen M, Kyvik K, Orstavik KH, Hegedus L: High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab. 2005, 90: 5949-5953. 10.1210/jc.2005-1366.CrossRefPubMed Brix TH, Knudsen GP, Kristiansen M, Kyvik K, Orstavik KH, Hegedus L: High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab. 2005, 90: 5949-5953. 10.1210/jc.2005-1366.CrossRefPubMed
13.
go back to reference Ozcelik T, Uz E, Akyerli CB, Bagislar S, Mustafa CA, Gursoy A, Akarsu N, Toruner G, Kamel N, Gullu S: Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet. 2006, 14: 791-797. 10.1038/sj.ejhg.5201614.CrossRefPubMed Ozcelik T, Uz E, Akyerli CB, Bagislar S, Mustafa CA, Gursoy A, Akarsu N, Toruner G, Kamel N, Gullu S: Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet. 2006, 14: 791-797. 10.1038/sj.ejhg.5201614.CrossRefPubMed
14.
go back to reference Yin X, Latif R, Tomer Y, Davies TF: Thyroid epigenetics: x-chromosome inactivation in patients with autoimmune thyroid disease. Ann N Y Acad Sci. 2007, 1110: 193-200. 10.1196/annals.1423.021.CrossRefPubMed Yin X, Latif R, Tomer Y, Davies TF: Thyroid epigenetics: x-chromosome inactivation in patients with autoimmune thyroid disease. Ann N Y Acad Sci. 2007, 1110: 193-200. 10.1196/annals.1423.021.CrossRefPubMed
15.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed
16.
go back to reference Kawazaki E: Sample preparation from blood, cells and other fluids. Origin of PCR protocols. A guide to methods and application. Edited by: Innis M, Gelffand D, Snisky G, White T. 1990, San Diego: Academic Press, 146-152. Kawazaki E: Sample preparation from blood, cells and other fluids. Origin of PCR protocols. A guide to methods and application. Edited by: Innis M, Gelffand D, Snisky G, White T. 1990, San Diego: Academic Press, 146-152.
17.
go back to reference Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet. 1992, 51: 1229-1239.PubMedCentralPubMed Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet. 1992, 51: 1229-1239.PubMedCentralPubMed
18.
go back to reference Delforge M, Demuynck H, Vandenberghe P, Verhoef G, Zachée P, van Duppen V, Marijnen P, Berghe Van den H, Boogaerts MA: Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood. 1995, 86: 3660-3667.PubMed Delforge M, Demuynck H, Vandenberghe P, Verhoef G, Zachée P, van Duppen V, Marijnen P, Berghe Van den H, Boogaerts MA: Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood. 1995, 86: 3660-3667.PubMed
19.
go back to reference Knudsen GP, Pedersen J, Klingenberg O, Lygren I, Ãrstavik KH: Increased skewing of X-chromosome inactivation with age in both blood and buccal cells. Cytogenet Genome Res. 2007, 116: 24-28. 10.1159/000097414.CrossRefPubMed Knudsen GP, Pedersen J, Klingenberg O, Lygren I, Ãrstavik KH: Increased skewing of X-chromosome inactivation with age in both blood and buccal cells. Cytogenet Genome Res. 2007, 116: 24-28. 10.1159/000097414.CrossRefPubMed
20.
go back to reference Abkowitz JL, Linenberger ML, Persik M, Newton MA, Guttorp P: Behavior of feline hematopoietic stem cells years after busulfan exposure. Blood. 1993, 82: 2096-2103.PubMed Abkowitz JL, Linenberger ML, Persik M, Newton MA, Guttorp P: Behavior of feline hematopoietic stem cells years after busulfan exposure. Blood. 1993, 82: 2096-2103.PubMed
21.
go back to reference Lockshin MD: Sex differences in autoimmune disease. Lupus. 2006, 15: 753-756. 10.1177/0961203306069353.CrossRefPubMed Lockshin MD: Sex differences in autoimmune disease. Lupus. 2006, 15: 753-756. 10.1177/0961203306069353.CrossRefPubMed
22.
go back to reference Chagnon P, Provost S, Belisle C, Bolduc V, Gingras M, Busque L: Age-associated skewing of X-inactivation ratios of blood cells in normal females: a candidate-gene analysis approach. Exp Hematol. 2005, 33: 1209-1214. 10.1016/j.exphem.2005.06.023.CrossRefPubMed Chagnon P, Provost S, Belisle C, Bolduc V, Gingras M, Busque L: Age-associated skewing of X-inactivation ratios of blood cells in normal females: a candidate-gene analysis approach. Exp Hematol. 2005, 33: 1209-1214. 10.1016/j.exphem.2005.06.023.CrossRefPubMed
23.
go back to reference Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993, 73: 147-157. 10.1016/0092-8674(93)90167-O.CrossRefPubMed Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993, 73: 147-157. 10.1016/0092-8674(93)90167-O.CrossRefPubMed
24.
go back to reference HernA¡ndez-Molina G, Svyryd Y, Sánchez-Guerrero J, Mutchinick OM: The role of the X-chromosome in immunity and autoimmunity. Autoimmun Rev. 2007, 6: 218-222. 10.1016/j.autrev.2006.08.004.CrossRef HernA¡ndez-Molina G, Svyryd Y, Sánchez-Guerrero J, Mutchinick OM: The role of the X-chromosome in immunity and autoimmunity. Autoimmun Rev. 2007, 6: 218-222. 10.1016/j.autrev.2006.08.004.CrossRef
25.
go back to reference Sharp A, Robinson D, Jacobs P: Age- and tissue-specific variation of X-chromosome inactivation ratios in normal women. Hum Genet. 2000, 107: 343-349. 10.1007/s004390000382.CrossRefPubMed Sharp A, Robinson D, Jacobs P: Age- and tissue-specific variation of X-chromosome inactivation ratios in normal women. Hum Genet. 2000, 107: 343-349. 10.1007/s004390000382.CrossRefPubMed
26.
go back to reference Azofeifa J, Waldherr R, Cremer M: X-chromosome methylation ratios as indicators of chromosomal activity: evidence of intraindividual divergencies among tissues of different embryonal origin. Hum Genet. 1996, 97: 330-333. 10.1007/BF02185765.CrossRefPubMed Azofeifa J, Waldherr R, Cremer M: X-chromosome methylation ratios as indicators of chromosomal activity: evidence of intraindividual divergencies among tissues of different embryonal origin. Hum Genet. 1996, 97: 330-333. 10.1007/BF02185765.CrossRefPubMed
27.
go back to reference Gale RE, Wheadon H, Boulos P, Linch DC: Tissue specificity of X-chromosome inactivation patterns. Blood. 1994, 83: 2899-2905.PubMed Gale RE, Wheadon H, Boulos P, Linch DC: Tissue specificity of X-chromosome inactivation patterns. Blood. 1994, 83: 2899-2905.PubMed
28.
go back to reference Chitnis S, Monteiro J, Glass D, Apatoff B, Salmon J, Concannon P, Gregersen PK: The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res. 2000, 2: 399-406. 10.1186/ar118.PubMedCentralCrossRefPubMed Chitnis S, Monteiro J, Glass D, Apatoff B, Salmon J, Concannon P, Gregersen PK: The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res. 2000, 2: 399-406. 10.1186/ar118.PubMedCentralCrossRefPubMed
29.
go back to reference Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK, Arnold AP, Singh RR, Voskuhl RR: A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med. 2008, 12: 1099-1108. 10.1084/jem.20070850.CrossRef Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK, Arnold AP, Singh RR, Voskuhl RR: A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med. 2008, 12: 1099-1108. 10.1084/jem.20070850.CrossRef
30.
go back to reference Naumova AK, Olien L, Bird LM, Smith M, Verner AE, Leppert M, Morgan K, Sapienza C: Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human. Eur J Hum Genet. 1998, 6: 552-562. 10.1038/sj.ejhg.5200255.CrossRefPubMed Naumova AK, Olien L, Bird LM, Smith M, Verner AE, Leppert M, Morgan K, Sapienza C: Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human. Eur J Hum Genet. 1998, 6: 552-562. 10.1038/sj.ejhg.5200255.CrossRefPubMed
31.
go back to reference Tomer Y, Davies TF: Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003, 24: 694-717. 10.1210/er.2002-0030.CrossRefPubMed Tomer Y, Davies TF: Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003, 24: 694-717. 10.1210/er.2002-0030.CrossRefPubMed
32.
go back to reference Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, Shimizu K, Yasuda N, Kamatani N, Takasugi K, Tanaka Y, Shiozawa K, Imura S: Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol. 1998, 10: 1891-1895. 10.1093/intimm/10.12.1891.CrossRefPubMed Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, Shimizu K, Yasuda N, Kamatani N, Takasugi K, Tanaka Y, Shiozawa K, Imura S: Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol. 1998, 10: 1891-1895. 10.1093/intimm/10.12.1891.CrossRefPubMed
33.
go back to reference Edwards CJ, Cooper C: Early environmental factors and rheumatoid arthritis. Clin Exp Immunol. 2005, 143: 1-5. 10.1111/j.1365-2249.2005.02940.x.CrossRef Edwards CJ, Cooper C: Early environmental factors and rheumatoid arthritis. Clin Exp Immunol. 2005, 143: 1-5. 10.1111/j.1365-2249.2005.02940.x.CrossRef
34.
go back to reference Guarneri F, Benvenga S: Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr Opin Endocrinol Diabetes Obes. 2007, 14: 398-409.CrossRefPubMed Guarneri F, Benvenga S: Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr Opin Endocrinol Diabetes Obes. 2007, 14: 398-409.CrossRefPubMed
Metadata
Title
Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases
Authors
Ghazi Chabchoub
Elif Uz
Abdellatif Maalej
Chigdem A Mustafa
Ahmed Rebai
Mouna Mnif
Zouheir Bahloul
Nadir R Farid
Tayfun Ozcelik
Hammadi Ayadi
Publication date
01-08-2009
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2009
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2759

Other articles of this Issue 4/2009

Arthritis Research & Therapy 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.